Use of transvenous DDD pacing in a one-year-old with symptomatic hypertrophic cardiomyopathy.
Symptomatic hypertrophic cardiomyopathy (HCM) is rare in infants. Therapeutic options are limited and include beta-blocker or calcium-channel blocker therapy or surgical myotomy/myectomy. Atrioventricular sequential pacing has been utilized as an alternative to surgery in symptomatic adults with HCM. We report our results with transvenous dual chamber pacing in an infant with symptomatic HCM.
Park
J K
JK
Department of Pediatrics, University of California at Davis School of Medicine, Sacramento 95817, USA.
Parrish
M D
MD
Pollock
M E
ME
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging / Q000628:therapy*; D004452:Echocardiography; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011433:Propranolol / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D011433:Propranolol